Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00971334 · ClinicalTrials.gov registry record
Noninvasive Screening for Fetal Aneuploidy: A New Maternal Plasma Marker
A clinical trial of Pregnancy and Down Syndrome, sponsored by Sequenom.
- Completed
- Registry status
- 2,502
- Enrollment target
- 20
- Study locations
NCT00971334: Completed study of Pregnancy and Down Syndrome, sponsored by Sequenom.
NCT00971334 is a study of Pregnancy and Down Syndrome that has completed, run by Sequenom. The registered enrollment target is 2,502 participants, above the 860-participant average among 191 other Pregnancy trials with a reported enrollment target (191% higher). The trial reports 20 study locations across 10 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00971334, a study of Pregnancy and Down Syndrome, has completed, sponsored by Sequenom.
- COMPLETED
- Registry status
- 2,502 participants
- Enrollment target
- 20
- Study locations
Study Summary
The purpose of this study is to collect samples for the purpose of developing a prenatal aneuploid test using circulating cell free fetal (ccff) nucleic acid from blood samples from pregnant women who have a high-risk pregnancy undergoing invasive prenatal diagnosis by chorionic villus sampling (CVS) and/or genetic amniocentesis. The results of the ccff aneuploid test will be compared to the chromosomal analysis obtained via CVS or amniocentesis.
Conditions Studied
Study Locations (20)
Florida
- Visions Clinical Research - Boynton Beach
- University of Miami - Miami
- South Florida Perinatal Medicine - Miami
- Global Ob/Gyn Centers - Pembroke Pines
- Discovery Clinical Research - Sunrise
- Sheridan Clinical Research - Sunrise
California
- Grossmont Center for Clinical Research - La Mesa
- IGO - San Diego
- San Diego Perinatal Center - San Diego
- Women's Healthcare at Frost Street - San Diego
- Poway Womens Care - San Diego
Michigan
- Spectrum Health - Maternal Fetal Medicine - Grand Rapids
- William Beaumont Hospital - Royal Oak
Alabama
- University of South Alabama - Mobile
Hawaii
- Fetal Diagnostic Institution of the Pacific - Honolulu
Idaho
- Women's Clinic - Boise
Illinois
- Reproductive Genetics Institute - Chicago
Minnesota
- Mayo Clinic - Rochester
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2,502 participants |
| Start Date | 2009-08 |
| Est. Completion | 2011-12 |
What the finished NCT00971334 record still lists
NCT00971334 is an observational study that tracks outcomes without assigning an intervention. Its 2,502 participants enrollment target places it among the larger protocols in the corpus, above the 860-participant average among 191 other Pregnancy trials with a reported enrollment target (191% higher).
The record links to 4 conditions, with Pregnancy appearing as the primary indexed condition, and to 0 interventions.
NCT00971334 names 20 study sites across 10 states, led by Florida, California, Michigan.
Frequently Asked Questions
What is clinical trial NCT00971334 about?
NCT00971334 is a clinical study titled "Noninvasive Screening for Fetal Aneuploidy: A New Maternal Plasma Marker". The purpose of this study is to collect samples for the purpose of developing a prenatal aneuploid test using circulating cell free fetal (ccff) nucleic acid from blood samples from pregnant women who have a high-risk pregnancy undergoing invasive prenatal diagnosis by chorionic villus sampling (CVS...
What is the current status of trial NCT00971334?
This trial is currently completed. The enrollment target is 2,502 participants. The study started on 2009-08. Estimated completion is 2011-12.
What conditions does trial NCT00971334 study?
This clinical trial studies the following conditions: Pregnancy, Down Syndrome, Aneuploidy, Edwards Syndrome.
Who is sponsoring clinical trial NCT00971334?
This trial is sponsored by Sequenom, which has 26 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00971334 being conducted?
This trial has 20 study locations across Alabama, California, Florida, Hawaii, Idaho. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Pregnancy
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT00971334's enrollment target sits among peer trials
2,502 13th of 191 higher than 179 of 191 other Pregnancy trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Pregnancy trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Stelara and Tremfya Pregnancy Exposure Registry OTIS Autoimmune Diseases in Pregnancy Project
RECRUITING
-
CGM Adherence Compared to Finger-stick Glucose Monitoring in Pregnancies With Type 2 Pregestational Diabetes
RECRUITING · NA
-
Healthy Start: Exploring the Fuel-mediated Programming of Neonatal Growth
RECRUITING
-
Cocooned Moms Study
RECRUITING · NA
-
Retinal Vascular Changes During Pregnancy
RECRUITING
-
CGM for Management of Type 2 Diabetes in Pregnancy
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00001160 · 2,500 participants
Studies on Tumors of the Thyroid
- NCT01904188 · 2,500 participants
Clinical Microbial Species & Antibiotic Resistance ID in ED Patients Presenting With Infection - is Rapid ID Possible & Accurate?
- NCT02257229 · 2,500 participants
Prospective Evaluation of Treatment for Clubfoot
- NCT02530658 · 2,500 participants
Next Generation Sequencing of Normal Tissues Prospectively in Pediatric Oncology Patients
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia